Hunger in the Absence of Caloric Restriction Improves Cognition and Attenuates Alzheimer's Disease Pathology in a Mouse Model

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Dhurandhar, Emily J ^a   Allison, David B ^a   van Groen, Thomas ^b   Kadish, Inga ^b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; GHRELIN; INTERLEUKIN 10; INTERLEUKIN 6;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; CALORIC RESTRICTION; CELL ACTIVATION; COGNITION; CONTROLLED STUDY; FAT MASS; HUNGER; LOCOMOTION; MALE; MAZE TEST; MENTAL PERFORMANCE; MICROGLIA; MOUSE; NONHUMAN; OPEN FIELD TEST; PROTEIN BLOOD LEVEL; TASK PERFORMANCE; WEIGHT REDUCTION;

ALZHEIMER DISEASE; ANIMALS; CALORIC RESTRICTION; COGNITION; DISEASE MODELS, ANIMAL; GHRELIN; HUNGER; MALE; MICE; MICE, INBRED C57BL;

EID: 84875656786     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060437     Document Type: Article

References (40)

1. Fontana L, Partridge L, Longo VD, (2010) Extending healthy life span--from yeast to humans. Science328: 321-326.
2. Colman RJ, Anderson RM, Johnson SC, Kastman EK, Kosmatka KJ, et al. (2009) Caloric restriction delays disease onset and mortality in rhesus monkeys. Science325: 201-204.
3. Wang J, Ho L, Qin W, Rocher AB, Seror I, et al. (2005) Caloric restriction attenuates beta-amyloid neuropathology in a mouse model of Alzheimer's disease. The FASEB journal: official publication of the Federation of American Societies for Experimental Biology 19: 659-661.
4. Wang J, Fivecoat H, Ho L, Pan Y, Ling E, et al. (2010) The role of Sirt1: at the crossroad between promotion of longevity and protection against Alzheimer's disease neuropathology. Biochim Biophys Acta 1804,1690-1694.
5. Bonda DJ, Lee HG, Camins A, Pallas M, Casadesus G, et al. (2011) The sirtuin pathway in ageing and Alzheimer disease: mechanistic and therapeutic considerations. Lancet Neurol 10,275-279.
6. Furuya TK, da Silva PN, Payao SL, Rasmussen LT, de Labio RW, et al. (2012) SORL1 and SIRT1 mRNA expression and promoter methylation levels in aging and Alzheimer's Disease. Neurochem Int.
7. Seneff S, Wainwright G, Mascitelli L, (2011) Nutrition and Alzheimer's disease: the detrimental role of a high carbohydrate diet. Eur J Intern Med22: 134-140.
8. Arab L, Sabbagh MN, (2010) Are certain lifestyle habits associated with lower Alzheimer's disease risk? J Alzheimers Dis20: 785-794.
9. Weih M, Wiltfang J, Kornhuber J, (2007) Non-pharmacologic prevention of Alzheimer's disease: nutritional and life-style risk factors. J Neural Transm114: 1187-1197.
10. Bales KR (2010) Brain lipid metabolism, apolipoprotein E and the pathophysiology of Alzheimer's disease. Neuropharmacology 59,295-302.
11. Shepardson NE, Shankar GM, Selkoe DJ (2011) Cholesterol level and statin use in Alzheimer disease: I. Review of epidemiological and preclinical studies. Arch Neurol 68,1239-1244.
12. Di Paolo G, Kim TW (2011) Linking lipids to Alzheimer's disease: cholesterol and beyond. Nat Rev Neurosci 12,284-296.
13. Shepardson NE, Shankar GM, Selkoe DJ (2011) Cholesterol level and statin use in Alzheimer disease: II. Review of human trials and recommendations. Arch Neurol 68,1385-1392.
14. Rattan SIS, (2004) Aging Intervention, Prevention, and Therapy Through Hormesis. Journal of Gernology: BIOLOGICAL SCIENCES59: 705-709.
15. Furst A (1987) Hormetic effects in pharmacology: pharmacological inversions as prototypes for hormesis. Health physics 52,527-530.
16. Libert S, Zwiener J, Chu X, Vanvoorhies W, Roman G, et al. (2007) Regulation of Drosophila life span by olfaction and food-derived odors. Science(New York, N.Y.) 315: 1133-1137.
17. Minor RK, Chang JW, de Cabo R (2009) Hungry for life: How the arcuate nucleus and neuropeptide Y may play a critical role in mediating the benefits of calorie restriction. Molecular and cellular endocrinology 299,79- 88.
18. Davidson TL, Kanoski SE, Tracy AL, Walls EK, Clegg D, et al. (2005) The interoceptive cue properties of ghrelin generalize to cues produced by food deprivation. Peptides 26,1602-1610.
19. Lugar CW, Clay MP, Lindstrom TD, Woodson AL, Smiley D, et al. (2004) Synthesis and biological evaluation of an orally active ghrelin agonist that stimulates food consumption and adiposity in rats. Bioorganic & medicinal chemistry letters 14,5873-5876.
20. Davis J, Xu F, Deane R, Romanov G, Previti ML, et al. (2004) Early-onset and robust cerebral microvascular accumulation of amyloid beta-protein in transgenic mice expressing low levels of a vasculotropic Dutch/Iowa mutant form of amyloid beta-protein precursor. J Biol Chem279: 20296-20306.
21. Giddings M, Cox J, & Allison DB (2008) in The Obesity Society Annual Meeting (Obesity, Phoenix, AZ), p. S108.
22. Hardy JA, Higgins GA, (1992) Alzheimer's disease: the amyloid cascade hypothesis. Science256: 184-185.
23. Halagappa VK, Guo Z, Pearson M, Matsuoka Y, Cutler RG, et al. (2007) Intermittent fasting and caloric restriction ameliorate age-related behavioral deficits in the triple-transgenic mouse model of Alzheimer's disease. Neurobiol Dis 26,212-220.
24. van Groen T, Kadish I (2005) Transgenic AD model mice, effects of potential anti-AD treatments on inflammation and pathology. Brain Res Brain Res Rev 48,370- 378.
25. Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, et al. (2000) Inflammation and Alzheimer's disease. Neurobiol Aging 21,383-421.
26. Rogers J, Lue LF (2001) Microglial chemotaxis, activation, and phagocytosis of amyloid beta-peptide as linked phenomena in Alzheimer's disease. Neurochem Int 39,333-340.
27. Stalder M, Deller T, Staufenbiel M, Jucker M (2001) 3D-Reconstruction of microglia and amyloid in APP23 transgenic mice: no evidence of intracellular amyloid. Neurobiol Aging 22,427-434.
28. Moon M, Choi JG, Nam DW, Hong HS, Choi YJ, et al. (2011) Ghrelin ameliorates cognitive dysfunction and neurodegeneration in intrahippocampal amyloid-beta1-42 oligomer-injected mice. J Alzheimers Dis23: 147-159.
29. Bulgarelli I, Tamiazzo L, Bresciani E, Rapetti D, Caporali S, et al. (2009) Desacyl-ghrelin and synthetic GH-secretagogues modulate the production of inflammatory cytokines in mouse microglia cells stimulated by beta-amyloid fibrils. J Neurosci Res87: 2718-2727.
30. Aziz NA, van der Marck MA, Pijl H, Olde Rikkert MG, Bloem BR, et al. (2008) Weight loss in neurodegenerative disorders. J Neurol255: 1872-1880.
31. Tamura BK, Masaki KH, Blanchette P, (2007) Weight loss in patients with Alzheimer's disease. J Nutr Elder26: 21-38.
32. Gillette Guyonnet S, Abellan Van Kan G, Alix E, Andrieu S, Belmin J, Berrut G, et al. (2007) IANA (International Academy on Nutrition and Aging) Expert Group: weight loss and Alzheimer's disease. J Nutr Health Aging11: 38-48.
33. Inelmen EM, Sergi G, Coin A, Girardi A, Manzato E (2010) An open-ended question: Alzheimer's disease and involuntary weight loss: which comes first? Aging Clin Exp Res 22,192-197.
34. Tezapsidis N, Johnston JM, Smith MA, Ashford JW, Casadesus G, et al. (2009) Leptin: a novel therapeutic strategy for Alzheimer's disease. J Alzheimers Dis16: 731-740.
35. Cai H, Cong WN, Ji S, Rothman S, Maudsley S, et al. (2012) Metabolic dysfunction in Alzheimer's disease and related neurodegenerative disorders. Curr Alzheimer Res 9,5-17.
36. Kivipelto M, Ngandu T, Fratiglioni L, Viitanen M, Kareholt I, et al. (2005) Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. Arch Neurol 62,1556-1560.
37. Whitmer RA, Gunderson EP, Barrett-Connor E, Quesenberry CP, Jr., Yaffe K (2005) Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study. BMJ 330,1360.
38. Refolo LM, Malester B, LaFrancois J, Bryant-Thomas T, Wang R, et al. (2000) Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model. Neurobiol Dis 7, 321-331.
39. Hambly C, Mercer JG, Speakman JR (2007) Hunger does not diminish over time in mice under protracted caloric restriction. Rejuvenation Res 10,533-542.
40. Diano S, Farr SA, Benoit SC, McNay EC, da Silva I, et al. (2006) Ghrelin controls hippocampal spine synapse density and memory performance. Nature neuroscience 9, 381-388.